# Multiple Skin Adnexal Tumours with Possible Syndromic Association

**Authors:** Janavi Sridhar, Archana Balasubramanian, Leena Joseph, Deyonna Fernandez, Ramesh B A

PMC · DOI: 10.7759/cureus.102352 · Cureus · 2026-01-26

## TL;DR

A woman in her fifties with multiple skin tumors was diagnosed with a possible CYLD cutaneous syndrome, a genetic condition linked to benign and malignant skin adnexal tumors.

## Contribution

The paper presents a clinical case highlighting the importance of considering syndromic associations in patients with multiple skin adnexal tumors.

## Key findings

- The patient had multiple skin adnexal tumors including eccrine spiradenoma, trichoepithelioma, and cylindroma.
- Histopathological analysis supported a possible syndromic association, prompting recommendation for CYLD gene testing.
- The tumors were located on the face, scalp, and upper back and showed progressive enlargement.

## Abstract

Brooke-Spiegler syndrome (BSS), multiple familial trichoepithelioma (MFT1) and familial cylindromatosis (FC) are autosomal dominant tumor syndromes that predispose individuals to multiple benign and malignant tumors, morphologically related to the adnexal structures of the skin. As allelic conditions caused by mutations in the CYLD gene, they are considered variants of a spectrum termed CYLD cutaneous syndrome (CCS). Patients commonly present with multiple adnexal tumors, such as cylindromas, trichoepitheliomas and spiradenomas, gradually increasing in size and number. Here, we report the case of a woman in her fifties who presented with an infected wound and multiple enlarging skin tumors over the face, scalp and upper back. Histopathological studies confirmed multiple skin adnexal tumors with features of eccrine spiradenoma, foci of trichoepithelioma and cylindroma areas. The patient underwent excision of the lesions with skin grafts and, given the possibility of syndromic association, was advised CYLD gene testing.

## Linked entities

- **Genes:** CYLD (CYLD lysine 63 deubiquitinase) [NCBI Gene 1540]
- **Diseases:** Brooke-Spiegler syndrome (MONDO:0011512), multiple familial trichoepithelioma (MONDO:0011114), familial cylindromatosis (MONDO:0007565), CYLD cutaneous syndrome (MONDO:0011512)

## Full-text entities

- **Genes:** TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, MAP3K7 (mitogen-activated protein kinase kinase kinase 7) [NCBI Gene 6885] {aka CSCF, FMD2, MEKK7, TAK1, TGF1a}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma) [NCBI Gene 8517] {aka AMCBX1, EDAID1, FIP-3, FIP3, Fip3p, IKK-gamma}, TRAF2 (TNF receptor associated factor 2) [NCBI Gene 7186] {aka MGC:45012, RNF117, TRAP, TRAP3}, BCL3 (BCL3 transcription coactivator) [NCBI Gene 602] {aka BCL4, D19S37}, CYLD (CYLD lysine 63 deubiquitinase) [NCBI Gene 1540] {aka BRSS, CDMT, CYLD1, CYLDI, EAC, FTDALS8}, MAPK14 (mitogen-activated protein kinase 14) [NCBI Gene 1432] {aka CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2}, TRAF6 (TNF receptor associated factor 6) [NCBI Gene 7189] {aka MGC:3310, RNF85}, SMAD7 (SMAD family member 7) [NCBI Gene 4092] {aka CRCS3, MADH7, MADH8}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, CCS (copper chaperone for superoxide dismutase) [NCBI Gene 9973], CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}
- **Diseases:** hematological malignancies (MESH:D019337), NF1 (MESH:D009456), seizures (MESH:D012640), cranial abnormalities (MESH:D003389), trichodiscomas (MESH:C536847), peripheral nerve sheath tumors (MESH:D018317), facies (MESH:D019066), Salivary gland tumors (MESH:D012468), itching (MESH:D011537), cutaneous lesions (MESH:D009059), bleeding (MESH:D006470), skin tumors (MESH:D012878), frontal bossing (MESH:D020233), Cutaneous adnexal tumors (MESH:D000292), Brooke-Spiegler syndrome (MESH:C536611), autosomal dominant tumor (MESH:D009369), dystrophic calcification (MESH:D002114), neuropsychiatric disorder (MESH:D001523), myeloma (MESH:D009101), swellings (MESH:D004487), nevoid basal cell carcinoma syndrome (MESH:D001478), Lisch nodules (MESH:C567588), fibrosis (MESH:D005355), melanoma (MESH:D008545), cylindroma (MESH:D003528), hematoma (MESH:D006406), neurodegenerative diseases (MESH:D019636), pain (MESH:D010146), renal angiomyolipomas (MESH:D018207), microcytic hypochromic anemia (MESH:C536357), skin appendage tumors (MESH:D018280), necrosis (MESH:D009336), basal cell carcinomas (MESH:D002280), Tuberous sclerosis complex (MESH:D014402), hepatocellular carcinoma (MESH:D006528), autosomal-dominant frontotemporal dementia (MESH:D057180), angiofibromas (MESH:D018322), pulmonary cysts (MESH:D003560), eccrine spiradenoma (MESH:D018250), dermal lesion (MESH:D016136), renal cell carcinomas (MESH:D002292), abnormalities in renal function (MESH:D007674), fungating scalp lesions (MESH:D004476), ungual fibromas (MESH:D005350), macrocephaly (MESH:D058627), cafe-au-lait macules (MESH:D019080), cataract (MESH:D002386), facial neoplasms (MESH:D005153), NF2 (MESH:D016518), pneumothorax (MESH:D011030), benign and malignant tumors (MESH:D018198), infected (MESH:D007239), infected ulcer (MESH:D014456), acral and plantar keratoses (MESH:D007642), skin adnexal tumors (MESH:D018294), jaw keratocysts (MESH:D009807), amyotrophic lateral sclerosis (MESH:D000690), neurofibromatosis (MESH:D017253), vestibulocochlear nerve involvement (MESH:D000160), anemia (MESH:D000740)
- **Chemicals:** cholesterol (MESH:D002784), iron (MESH:D007501), mupirocin (MESH:D016712), amoxicillin/clavulanate (MESH:D019980), Eosin (MESH:D004801), folic acid (MESH:D005492), cefazolin (MESH:D002437), ceftriaxone (MESH:D002443), cephalosporins (MESH:D002511), H&amp;E (MESH:D006371), Hematoxylin (MESH:D006416), sulbactam (MESH:D013407)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12936400/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12936400/full.md

## References

16 references — full list in the complete paper: https://tomesphere.com/paper/PMC12936400/full.md

---
Source: https://tomesphere.com/paper/PMC12936400